Background: Maternal obesity is increasing. There is growing evidence of its effect
| INTRODUC TI ON
Obesity is a significant health concern among women of reproductive age and trends mirror those of the general population in most high-income countries. Maternal obesity prevalence rates increased from 6.0% to 11.8% between 1998 and 2016 in France and from 17.6% to 20.5% in the United States between 2003 and 2009, with evidence of accelerating incidence. [1] [2] [3] Obesity during pregnancy is associated with an increased risk of adverse perinatal outcomes and higher health care costs. 4, 5 Maternal outcomes associated with obesity include higher rates of pre-eclampsia and gestational diabetes, [6] [7] [8] prolonged labour progression, 9 higher rates of caesarean delivery, 10, 11 and an increased risk for postpartum haemorrhage independent of mode of delivery in some settings.
12-14
Despite the increased incidence of complications during pregnancy and delivery among obese women, few studies have investigated the effect of maternal obesity on severe complications leading to profound alterations in the mother's health, that is, severe maternal morbidity (SMM). [15] [16] [17] [18] [19] These studies have utilised varying definitions of the SMM composite outcome and approaches to case ascertainment. To our knowledge, no study has examined SMM occurrence by timing and few have investigated SMM by cause.
In a population-based case-control study, we examined the association between maternal obesity and SMM overall, by the timing of SMM occurrence (ie, antepartum or intrapartum/postpartum), and by pathologic cause.
| ME THODS
We performed an unmatched case-control analysis within EPIMOMS, a population-based prospective investigation designed specifically to study SMM in six French regions between May 2012 and November 2013. The study sample was selected from a source population of 182 309 pregnant women receiving care at 119 public maternity units and 136 intensive care units.
The source population constituted one-fifth of all deliveries in
France, and maternal characteristics were similar to that of the national obstetric population. 3 Women ≥18 years old who delivered at ≥22 weeks of gestational age were eligible for study inclusion. The study was approved by the Commission Nationale de l'Informatique et des Libertés (CNIL, no 912210), the French data protection agency.
| Severe maternal morbidity case and controls
The definition of a SMM event was developed via an extensive national expert Delphi consensus process, with the objective of isolating those maternal complications which result in severe health alteration. The national panel of professionals included obstetricians (n = 16), midwives (n = 5), anaesthesiologists/intensive care specialists (n = 8), and public health specialists (n = 3). The process followed a Delphi-Rand design and consisted of two rounds followed by a final plenary session. The level of consensus for each round was fixed at 70%. Once the definition for SMM was finalised, its comprehensiveness was tested via a population-based survey, which was used to study the incidence, the causes, and the risk factors of SMM in six regions across France.
The final EPIMOMS definition of SMM combines diagnostic criteria (major obstetric bleeding, eclampsia, severe pre-eclampsia, pulmonary embolism, stroke, selected psychiatric disorders), organ dysfunction criteria (hepatic, haematologic, respiratory, cardiovascular, renal, neurological), and interventional criteria (admission to ICU, laparotomy after delivery). The EPIMOMS SMM case criteria are detailed in Table 1 .
All women who experienced a SMM event in the source population during the study period and were between 22 weeks of gestation and 42 days postpartum were included in the EPIMOMS study.
A SMM event was defined as per the EPIMOMS case criteria. They were prospectively identified by care providers, and completeness of case ascertainment and timing of SMM occurrence (ie, antepartum, intrapartum/postpartum) were checked via a review of delivery log books, birth registers, hospital discharge databases, and laboratory records and validated by clinicians who worked at the health centres. Women who experienced more than one SMM event in the antepartum and intra/postpartum periods were only counted once in the analysis of overall SMM. In the EPIMOMS cohort, 2540
women experienced SMM (1.4%) and constituted the case group in this case-control analysis. SMM case inclusion criteria based on organ dysfunction or a management indicator did not necessarily directly correspond to the cause of SMM. Therefore, the SMM causal condition, as identified by the clinician in charge, was also recorded for all cases.
A random 2% unmatched sample of women who delivered at ≥22 weeks of gestation without experiencing a SMM event from the same health centres during the study period was selected as the control group (n = 3651). Based on an anticipated rate of Conclusion: Obesity is associated with an increased risk of antepartum, but not intra/ postpartum, severe maternal morbidity. 
| Statistical analysis
Categorical prepregnancy body mass index (BMI; kg/m 2 ) was the independent variable of interest in all models (underweight: BMI <18.5; normal weight: BMI 18.5-24.9; overweight: BMI 25-29.9; obese: BMI ≥30). Prepregnancy BMI was extracted from the medical chart and was calculated from self-reported prepregnancy weight and height at the initial prenatal visit. SMM events were described by timing and cause (underlying causal conditions are listed in Table 3 ), and obesity status. Demographic, medical, and facility characteristics were further described by BMI category among controls only, in order to be reflective of the general population and to assess for potential confounders. Directed acyclic graphs (DAGs) were used to inform the selection of co-variables in the multivariable logistic regression models of SMM outcomes: overall, by timing of occurrence (antepartum and intrapartum/postpartum), and by most common causes. We used the web-based application DAGitty (www.dagitty.net) to create our DAGs ( Figure S1 ). We included only confounders (ie, factors potentially associated with both the exposure and the outcome) in the final multivariable models and not intermediates in the causal pathway between obesity and SMM in order to avoid over-adjusting the measurement of the association between BMI and SMM. 20 In particular, pre-existing chronic hypertension and type 2 diabetes were considered to be mediators of the pathway and not confounders and therefore were not 
| Missing data
The proportion of missing data for all variables in the final model was <10% except for maternal place of birth (14%) and profession (11%), and 19% of women had at least one missing variable. The proportion of missing BMI data was 7% among cases and 4% among controls. Multiple imputation using chained equations was performed over 25 cycles to handle missing data assumed to be missing at random (MAR). 
| RE SULTS
Characteristics of study participants by case-control status are shown in Table 2 . As compared to controls, women experiencing SMM were more likely to be obese (15% vs 11% In the current pregnancy, they had higher rates of in vitro fertilisation, multiple gestation, hypertensive disease, and delivered at earlier gestational ages.
In order to identify risk factors associated with obesity that could be possible confounders of the association between obesity and SMM, characteristics of controls were analysed according to their obese or non-obese status (Table S1 ). Among controls, obese women were more likely to be older, from North Africa, be manual service workers, have a history of chronic hypertension, pre-existing diabetes, multiparous with prior caesarean deliveries, and have prior hypertensive disorders of pregnancy; they were also more likely to have a hypertensive disorder and gestational diabetes in the current pregnancy and were more likely to be induced, have a caesarean delivery, and a higher newborn birthweight. There was no difference in the distribution of BMI category by facility type, level of care, or delivery volume among controls.
The majority of SMM events occurred in intra/postpartum (Table 3 ). The most common causes of SMM overall were severe haemorrhage and severe hypertensive disorders, with the former accounting for most intra/postpartum SMM cases and the latter for most antepartum SMM cases. Among women experiencing SMM, obese women had higher proportion of antepartum SMM and of severe hypertensive disorders, in particular preeclampsia-related SMM, than non-obese women. Babies born to women experiencing antepartum SMM were more likely to be born preterm as compared to controls or to women experiencing intra/postpartum SMM, primarily as a result of caesarean delivery without a trial of labour (Table S2 ).
The association between prepregnancy BMI and SMM is shown in Table 4 . Prepregnancy obesity was associated with overall SMM and antepartum SMM, but not with intra/postpartum SMM. Among women with antepartum SMM, severe hypertensive disorders had the strongest association with obesity, and this association was mainly driven by preeclampsia-related SMM, but the risk of antepartum SMM from all other causes combined was also increased among obese women. Obesity was not associated with the risk of severe postpartum haemorrhage. Results of the full models with all co-variable adjusted odds ratios and 95% confidence intervals appear in Table S3 . Among other risk factors, maternal place of birth was most strongly associated with SMM and sub-Saharan African mothers had an increased risk of SMM at all times. a Haematologic disease or hemoglobinopathy, psychiatric illness, history of venous thromboembolism, coronary artery disease, cardiomyopathy, congestive heart failure, epilepsy, multiple sclerosis, liver disease including infectious hepatitis, autoimmune disease, inflammatory bowel disease, nephropathy, history of haemodialysis, pulmonary disease, myasthenia gravis, neoplasia, HIV, and any other chronic medical condition.
TA B L
E 2 Characteristics among women experiencing severe maternal morbidity (SMM) and those not experiencing
TA B L E 2 (Continued)
TA B L E 3 Diagnosis of severe maternal morbidity (SMM) cases by timing, cause, and obesity status (15) 272 (20) 101 (21) 95 (27) Preeclampsia 340 (13) 17 (10) 175 (13) 71 (15) 77 (22) Eclampsia 43 (2) 1 (1) 25 (2) 8 (2) 9 (3) HELLP Syndrome 163 (6) 11 (7) 96 (7) 33 (7) 23 (6) Placental abruption 82 (3) 3 (2) 50 (4) 21 (4) 8 (2) Sepsis 52 (2) 2 (1) 31 (2) 7 (2) 7 (2) Decompensation of pre-existing medical condition
108 (4) 3 (2) 50 (4) 14 (3) 14 (4) Psychiatric disorder 88 (4) 6 (4) 52 (4) 17 (4) 13 (4) Pulmonary embolus 39 (2) 23 (14) 1 (0) 6 (1) 7 (2) Cerebrovascular accident 35 (1) 15 (9) 2 (0) 9 (2) 3 (1) Amniotic fluid embolus 15 (1) 10 (6) 0 (0) 1 (0) 2 (1) Other 218 (9) 16 (9) 109 (8) 40 (8) 35 (10) Multiple pathologies 219 (9) 6 (4) 114 (8) 38 (8) 25 (7) Antepartum SMM cases a 598 (24) c 28 (17) 288 (21) 110 (23) 121 (34) Severe obstetrical haemorrhage 83 (14) 3 (11) 48 (17) 10 (9) 15 (12) Severe hypertensive disorder Psychiatric disorder 54 (9) 4 (14) 24 (8) 10 (9) 5 (4) Pulmonary embolus 15 (3) 1 (4) 9 (3) 1 (1) 3 (3) Cerebrovascular accident 17 (3) 1 (4) 7 (2) 6 (6) 1 (1) Amniotic fluid embolus
Other 94 (16) 6 (21) 47 (16) 14 (13) 23 (19) Multiple pathologies 94 (16) 2 (7) 48 (17) 16 (15) 17 (14) Intrapartum 
Decompensation of pre-existing medical condition
Pulmonary embolus 24 (1) 0 (0) 14 (1) 5 (1) 4 (2) (Continues)
| COMMENT

| Principal findings
We found that maternal obesity is associated with an increased risk of SMM in the antepartum period primarily due to severe hypertensive disorders, with no increased risk of SMM intrapartum or postpartum. The risk of antepartum SMM due to causes other than severe hypertensive disorders was also increased among obese mothers.
| Strengths of the study
This study had several strengths. The comprehensiveness and high quality of data in the EPIMOMS cohort and rigorous case ascertainment based on expert consensus allowed for more robust results as compared to the prior mixed and often contradictory data on the association between obesity and SMM. Conducting the investigation in France limited confounding bias related to socio-economic status as the health system allows universal access to care, although potential differences in health outcomes due to income are not entirely eliminated. Finally, the EPIMOMS dataset included exhaustive detailed information regarding participants' pregnancies and allowed for a novel analysis of SMM by clinical timing.
| Limitations of the data
This study was limited by the moderate prevalence of obesity and morbid obesity in France; thus, the findings may not be generalisable to other high-income countries that have a greater prevalence of obesity. In addition to prepregnancy BMI, adiposity and gestational weight gain may be alternate markers of risk, especially in predicting SMM due to severe hypertensive disorders. The use of a composite SMM outcome may in theory bias the results towards null due to the possibility of a heterogeneity of associations. However, it is useful to have the overall SMM composite outcome for comparability with other studies. Furthermore, we did examine the most common single causes of SMM separately. Despite the relatively large study size, we were unable to study less common causes of SMM, similar to prior investigations. Finally, only a limited number of socio-demographic confounders were included in the analysis due to data availability, so the potential for unmeasured confounding on the associations remains.
| Interpretation
Limited previous data exist examining maternal obesity and SMM.
A Dutch case-control study of 4561 low-risk pregnant women found a dose-response relationship between overweight, obesity, and morbid obesity and composite SMM outcome. (6) 10 (7) 62 (6) 26 (7) 12 (5) Multiple pathologies 122 (6) 4 (3) 66 (6) 22 (6) 8 (3) a Percentage total greater than 100 due to possibility of multiple diagnoses. 
| CON CLUS IONS
Severe maternal morbidity and mortality constitute a notable burden of disease and both are increasing in some developed countries. 33 Identifying modifiable risk factors is therefore necessary.
These findings underscore the importance of reducing obesity among women of reproductive age and improving the quality of prenatal care and blood pressure monitoring among obese women. Odds ratios were adjusted for the confounding effects of maternal age, prepregnancy tobacco use, maternal place of birth, living alone, profession, and parity.
